PEAR logo

Pear Therapeutics (PEAR) EBITDA

Annual EBITDA

-$117.65 M
-$14.21 M-13.74%

December 31, 2022

Summary

Performance

1-Year Change

-13.74%

3-Year Change

-274.75%

5-Year Change

-274.75%

15-Year Change

-274.75%

PEAR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$31.39 M

3-Year Low

-$117.65 M
PEAR annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PEAR previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PEAR next annual earnings announcement has not yet been scheduled

OtherPEARprofitabilitymetrics:

Annual Revenue

$12.69 M
PEAR annual revenue is $12.69 million

Annual Net Income

-$75.49 M
PEAR annual net profit is -$75.49 million

Annual EBIT

-$123.35 M
PEAR annual earnings before interest & taxes is -$123.35 million

Annual EPS

-$0.54
PEAR annual earnings per share is -$0.54

Quarterly EBITDA

-$27.63 M
-$2.47 M-9.82%

December 31, 2022

Summary

Performance

3-Month Change

-9.82%

1-Year Change

+17.5%

3-Year Change

-50.87%

5-Year Change

-50.87%

PEAR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$18.31 M

3-Year Low

-$33.49 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
PEAR previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
PEAR next earnings announcement has not yet been scheduled

OtherPEARprofitabilitymetrics:

Quarterly Revenue

$2.56 M
PEAR quarterly revenue is $2.56 million

Quarterly Net Income

-$26.37 M
PEAR quarterly net profit is -$26.37 million

Quarterly EBIT

-$29.16 M
PEAR quarterly earnings before interest & taxes is -$29.16 million

Quarterly EPS

-$0.19
PEAR quarterly earnings per share is -$0.19

TTM EBITDA

-$117.65 M
+$5.86 M+4.75%

December 31, 2022

Summary

Performance

3-Month Change

+4.75%

1-Year Change

-13.74%

3-Year Change

-542.46%

5-Year Change

-542.46%

PEAR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$18.31 M

3-Year Low

-$125.92 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
PEAR previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
PEAR next earnings announcement has not yet been scheduled

OtherPEARprofitabilitymetrics:

TTM Revenue

$12.69 M
PEAR TTM revenue is $12.69 million

TTM Net Income

-$75.49 M
PEAR TTM net profit is -$75.49 million

TTM EBIT

-$123.35 M
PEAR TTM earnings before interest & taxes is -$123.35 million

TTM EPS

-$0.54
PEAR TTM earnings per share is -$0.54

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$117.65 M
PEAR annual EBITDA is -$117.65 million

Annual Net Income

-$75.49 M
PEAR annual net profit is -$75.49 million

Annual Interest Expense

-
PEAR annual interest expense value is unknown

Annual Income Tax

-
PEAR annual income tax value is unknown

Annual D&A

$5.70 M
PEAR annual depreciation & amortization is $5.70 million

PEAR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.7%+17.5%-13.7%
3 y3 years-274.8%-50.9%-542.5%
5 y5 years-274.8%-50.9%-542.5%

PEAR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+13.7%at low+9.8%+21.2%+13.7%+7.0%
5 y5-year+274.7%at low+50.9%+21.2%+542.5%+7.0%
alltimeall time+274.7%at low+50.9%+21.2%+542.5%+7.0%

Pear Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2022
-$117.65 M(+13.7%)
-$27.63 M(+9.8%)
-$117.65 M(-4.7%)
Sep 2022
-
-$25.16 M(-19.9%)
-$123.51 M(-1.9%)
Jun 2022
-
-$31.42 M(-6.1%)
-$125.92 M(+8.5%)
Mar 2022
-
-$33.45 M(-0.1%)
-$116.10 M(+12.3%)
Dec 2021
-$103.43 M
-$33.49 M(+21.5%)
-$103.43 M(+4.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$27.57 M(+27.6%)
-$98.98 M(+10.3%)
Jun 2021
-
-$21.60 M(+4.0%)
-$89.72 M(+31.7%)
Mar 2021
-
-$20.77 M(-28.4%)
-$68.12 M(+43.9%)
Dec 2020
-$76.21 M(+142.8%)
-$29.03 M(+58.6%)
-$47.35 M(+158.6%)
Sep 2020
-
-$18.31 M
-$18.31 M
Dec 2019
-$31.39 M
-
-

FAQ

  • What is Pear Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Pear Therapeutics?
  • What is Pear Therapeutics annual EBITDA year-on-year change?
  • What is Pear Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Pear Therapeutics?
  • What is Pear Therapeutics quarterly EBITDA year-on-year change?
  • What is Pear Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Pear Therapeutics?
  • What is Pear Therapeutics TTM EBITDA year-on-year change?

What is Pear Therapeutics annual EBITDA?

The current annual EBITDA of PEAR is -$117.65 M

What is the all time high annual EBITDA for Pear Therapeutics?

Pear Therapeutics all-time high annual EBITDA is -$31.39 M

What is Pear Therapeutics annual EBITDA year-on-year change?

Over the past year, PEAR annual EBITDA has changed by -$14.21 M (-13.74%)

What is Pear Therapeutics quarterly EBITDA?

The current quarterly EBITDA of PEAR is -$27.63 M

What is the all time high quarterly EBITDA for Pear Therapeutics?

Pear Therapeutics all-time high quarterly EBITDA is -$18.31 M

What is Pear Therapeutics quarterly EBITDA year-on-year change?

Over the past year, PEAR quarterly EBITDA has changed by +$5.86 M (+17.50%)

What is Pear Therapeutics TTM EBITDA?

The current TTM EBITDA of PEAR is -$117.65 M

What is the all time high TTM EBITDA for Pear Therapeutics?

Pear Therapeutics all-time high TTM EBITDA is -$18.31 M

What is Pear Therapeutics TTM EBITDA year-on-year change?

Over the past year, PEAR TTM EBITDA has changed by -$14.21 M (-13.74%)